1. Home
  2. CHCO vs HROW Comparison

CHCO vs HROW Comparison

Compare CHCO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo City Holding Company

CHCO

City Holding Company

HOLD

Current Price

$132.05

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$42.44

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHCO
HROW
Founded
1957
1998
Country
United States
United States
Employees
N/A
373
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CHCO
HROW
Price
$132.05
$42.44
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$132.50
$69.86
AVG Volume (30 Days)
130.1K
807.0K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.87%
N/A
EPS Growth
13.18
N/A
EPS
2.20
N/A
Revenue
N/A
N/A
Revenue This Year
$5.16
$31.62
Revenue Next Year
$3.12
$50.77
P/E Ratio
$59.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$113.21
$28.54
52 Week High
$134.92
$54.98

Technical Indicators

Market Signals
Indicator
CHCO
HROW
Relative Strength Index (RSI) 62.35 64.39
Support Level $120.29 $40.61
Resistance Level N/A $44.50
Average True Range (ATR) 2.85 2.29
MACD 0.37 0.34
Stochastic Oscillator 71.02 81.46

Price Performance

Historical Comparison
CHCO
HROW

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: